179 related articles for article (PubMed ID: 10553700)
1. Activity of quinolones against mycobacteria.
Jacobs MR
Drugs; 1999; 58 Suppl 2():19-22. PubMed ID: 10553700
[TBL] [Abstract][Full Text] [Related]
2. Activity of quinolones against mycobacteria.
Jacobs MR
Drugs; 1995; 49 Suppl 2():67-75. PubMed ID: 8549419
[TBL] [Abstract][Full Text] [Related]
3. In-vitro activity of quinolones and macrolides against mycobacteria.
Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF
J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria].
Kawahara S; Tada A; Nagare H
Kekkaku; 2001 Apr; 76(4):357-62. PubMed ID: 11398326
[TBL] [Abstract][Full Text] [Related]
5. Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria.
Guillemin I; Jarlier V; Cambau E
Antimicrob Agents Chemother; 1998 Aug; 42(8):2084-8. PubMed ID: 9687411
[TBL] [Abstract][Full Text] [Related]
6. [Antimycobacterial activities of a new quinolone, sparfloxacin].
Tomioka H; Sato K; Saito H
Kekkaku; 1991 Oct; 66(10):643-9. PubMed ID: 1660089
[TBL] [Abstract][Full Text] [Related]
7. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
Casal M; Gutierrez J; Ruiz P; Moreno G
Chemotherapy; 1995; 41(3):204-7. PubMed ID: 7656667
[TBL] [Abstract][Full Text] [Related]
8. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
Vacher S; Pellegrin JL; Leblanc F; Fourche J; Maugein J
J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
[TBL] [Abstract][Full Text] [Related]
9. [In vitro antimycobacterial activity of a new quinolone, NM394].
Tomioka H; Sato K; Saito H
Kekkaku; 1993 Aug; 68(8):517-20. PubMed ID: 8397311
[TBL] [Abstract][Full Text] [Related]
10. The clinical use of fluoroquinolones for the treatment of mycobacterial diseases.
Alangaden GJ; Lerner SA
Clin Infect Dis; 1997 Nov; 25(5):1213-21. PubMed ID: 9402384
[TBL] [Abstract][Full Text] [Related]
11. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
Dailloux M; Petitpain N; Henry C; Weber M
Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
[TBL] [Abstract][Full Text] [Related]
12. Purification and inhibition by quinolones of DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum.
Guillemin I; Sougakoff W; Cambau E; Revel-Viravau V; Moreau N; Jarlier V
Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2527-2532. PubMed ID: 10517605
[TBL] [Abstract][Full Text] [Related]
13. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin.
Tomioka H; Saito H; Sato K
Antimicrob Agents Chemother; 1993 Jun; 37(6):1259-63. PubMed ID: 8392307
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic potential of sparfloxacin for preventing mycobacterial infections].
Kawahara S; Tada A; Takeuchi M; Kamisaka K; Okada C; Mishima Y; Soda R; Takahashi K; Kibata M; Nagare H
Kekkaku; 1994 May; 69(5):351-6. PubMed ID: 8007520
[TBL] [Abstract][Full Text] [Related]
15. Sequences of conserved region in the A subunit of DNA gyrase from nine species of the genus Mycobacterium: phylogenetic analysis and implication for intrinsic susceptibility to quinolones.
Guillemin I; Cambau E; Jarlier V
Antimicrob Agents Chemother; 1995 Sep; 39(9):2145-9. PubMed ID: 8540734
[TBL] [Abstract][Full Text] [Related]
16. [In vitro antimycobacterial activity of a new quinolone, T-3761].
Tomioka H; Sato K; Saito H
Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
[TBL] [Abstract][Full Text] [Related]
17. [Antimycobacterial activity of a newly synthesized fluoroquinolone, Y-26611].
Tomioka H; Sato K; Saito H; Ikeda Y
Kekkaku; 1992 Jul; 67(7):515-20. PubMed ID: 1331603
[TBL] [Abstract][Full Text] [Related]
18. Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp.
Van Caekenberghe D
J Antimicrob Chemother; 1990 Sep; 26(3):381-6. PubMed ID: 2228828
[TBL] [Abstract][Full Text] [Related]
19. Comparative in-vitro activity of sparfloxacin and eight other antimicrobial agents against clinical isolates of non-tuberculous mycobacteria.
Sánchez-Carrillo C; Cotarelo M; Cercenado E; Vicente T; Blázquez R; Bouza E
J Antimicrob Chemother; 1996 Jan; 37(1):151-4. PubMed ID: 8647757
[TBL] [Abstract][Full Text] [Related]
20. N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies.
Klopman G; Fercu D; Renau TE; Jacobs MR
Antimicrob Agents Chemother; 1996 Nov; 40(11):2637-43. PubMed ID: 8913479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
